Tissue Regenix (UK) Performance
| TRX Stock | 58.50 1.50 2.50% |
Tissue Regenix has a performance score of 7 on a scale of 0 to 100. The entity has a beta of -0.28, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Tissue Regenix are expected to decrease at a much lower rate. During the bear market, Tissue Regenix is likely to outperform the market. Tissue Regenix Group right now has a risk of 1.56%. Please validate Tissue Regenix value at risk, kurtosis, market facilitation index, as well as the relationship between the semi variance and rate of daily change , to decide if Tissue Regenix will be following its existing price patterns.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Tissue Regenix Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Tissue Regenix may actually be approaching a critical reversion point that can send shares even higher in February 2025. ...more
Last Split Factor 1:100 | Last Split Date 2023-04-28 |
1 | Tissue Regenix Sees Shift in IP Group Voting Rights - TipRanks | 12/09/2024 |
| Begin Period Cash Flow | 5.9 M |
Tissue |
Tissue Regenix Relative Risk vs. Return Landscape
If you would invest 5,400 in Tissue Regenix Group on October 7, 2024 and sell it today you would earn a total of 450.00 from holding Tissue Regenix Group or generate 8.33% return on investment over 90 days. Tissue Regenix Group is generating 0.1391% of daily returns and assumes 1.5641% volatility on return distribution over the 90 days horizon. Simply put, 13% of stocks are less volatile than Tissue, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Tissue Regenix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tissue Regenix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Tissue Regenix Group, and traders can use it to determine the average amount a Tissue Regenix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0889
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | TRX | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.56 actual daily | 13 87% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Tissue Regenix is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tissue Regenix by adding it to a well-diversified portfolio.
Tissue Regenix Fundamentals Growth
Tissue Stock prices reflect investors' perceptions of the future prospects and financial health of Tissue Regenix, and Tissue Regenix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tissue Stock performance.
| Return On Equity | -0.0331 | ||||
| Return On Asset | 0.005 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 47.34 M | ||||
| Shares Outstanding | 71.23 M | ||||
| Price To Book | 1.72 X | ||||
| Price To Sales | 1.31 X | ||||
| Revenue | 29.49 M | ||||
| Gross Profit | 11.26 M | ||||
| EBITDA | 446 K | ||||
| Net Income | (1.67 M) | ||||
| Total Debt | 9.39 M | ||||
| Book Value Per Share | 0.43 X | ||||
| Cash Flow From Operations | 1.04 M | ||||
| Earnings Per Share | (0.01) X | ||||
| Total Asset | 43.24 M | ||||
| Retained Earnings | (123.76 M) | ||||
About Tissue Regenix Performance
By analyzing Tissue Regenix's fundamental ratios, stakeholders can gain valuable insights into Tissue Regenix's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Tissue Regenix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tissue Regenix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Tissue Regenix is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Tissue Regenix Group performance evaluation
Checking the ongoing alerts about Tissue Regenix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tissue Regenix Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 29.49 M. Net Loss for the year was (1.67 M) with profit before overhead, payroll, taxes, and interest of 11.26 M. | |
| About 52.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Tissue Regenix Sees Shift in IP Group Voting Rights - TipRanks |
- Analyzing Tissue Regenix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tissue Regenix's stock is overvalued or undervalued compared to its peers.
- Examining Tissue Regenix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tissue Regenix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tissue Regenix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tissue Regenix's stock. These opinions can provide insight into Tissue Regenix's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Tissue Stock analysis
When running Tissue Regenix's price analysis, check to measure Tissue Regenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tissue Regenix is operating at the current time. Most of Tissue Regenix's value examination focuses on studying past and present price action to predict the probability of Tissue Regenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tissue Regenix's price. Additionally, you may evaluate how the addition of Tissue Regenix to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |